Unlocking Glaucoma Management: Insights from Dr. Deb Ristvedt at ASCRS 2025 on Medications, Lasers, and Lifestyle

At the recent 2025 American Society of Cataract and Refractive Surgery meeting in Los Angeles, Dr. Deb Ristvedt led an engaging discussion on the evolving landscape of glaucoma treatments. She noted that the field is rapidly changing, emphasizing a shift toward less reliance on eye drops and earlier interventions.

The session highlighted advancements in drug delivery techniques, particularly focusing on how new medications are designed to maintain effects at the trabecular meshwork for longer periods. According to Dr. Rhee, using these advanced formulations can help keep intraocular pressure stable for 24 hours. Ristvedt pointed out, “We now have medications that offer more concentrated delivery to the eye, allowing better long-term control.” This means patients might see fewer fluctuations in their eye pressure and reduced risk of vision loss over time.

Laser treatments are also experiencing breakthroughs. The group revisited findings from the LiGHT trial, which suggested that selective laser trabeculoplasty (SLT) should be considered a first-line treatment. Excitingly, they introduced a new technique known as direct SLT, which can deliver energy in just 2.6 seconds. Ristvedt explained, “This method targets the trabecular meshwork directly and eliminates the need for a gonio lens, making the procedure easier for both patients and surgeons.” This advancement not only improves patient comfort but also reduces the physical strain on surgeons.

Beyond medical innovations, Ristvedt stressed the importance of considering lifestyle factors in glaucoma management. “How we live affects our overall quality of life,” she mentioned, pushing for a more holistic approach to patient care. As awareness grows, patients and healthcare providers alike are encouraged to adopt healthier routines that can positively influence glaucoma treatment outcomes.

Overall, the session painted a hopeful picture for glaucoma treatment. With ongoing research and technology advancements, the future looks promising. Awareness of these developments is crucial as they could lead to better patient experiences and improved management of this chronic condition. For a deeper dive into the latest in glaucoma treatment, check out resources from the American Academy of Ophthalmology for more insights.

Source link

Ophthalmology Times